Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

NKTRNKTR
5 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in Nektar Therapeutics

GEODE CAPITAL MANAGEMENT, LLC holds 881,306 shares of NKTR (Nektar Therapeutics), worth $61.5M as of 2026-Q2. The position was increased (+154.1% shares). NKTR represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$61.5M

Current Shares

881,306

Total Value Change

+$58.1M

Total Shares Change

+748,933

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
881,306
+154.1%
$61.5M0.0%$69.81
48
2026-Q1
Increased
346,795
+36.3%
$25M0.0%$68.11
37
2025-Q4
Increased
254,361
+12.9%
$10.8M0.0%$41.90
31
2025-Q3
Increased
225,236
+70.2%
$12.8M0.0%$58.92
42
2025-Q2
New
132,373
-
$3.4M0.0%$25.76
37

Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used